Merck surges after robust Q4 numbers

Merck was up 4.16% to Rs 1,503.90 at 10:43 IST on BSE after net profit surged 40.22% to Rs 27.26 crore on 15.63% growth in total income to Rs 309.52 crore in Q4 December 2017 over Q4 December 2016.

The results were announced after market hours yesterday, 22 February 2018.

Meanwhile, the S&P BSE Sensex was up 163.93 points or 0.48% at 33,983.43. The S&P BSE Small-Cap index surged 1.19%, outperforming the Sensex.

On the BSE, 4,714 shares were traded on the counter so far as against average daily volumes of 7,062 shares in the past one quarter. The stock had hit a high of Rs 1,517.50 and a low of Rs 1,455 so far during the day. The stock had hit a record high of Rs 1,687.30 on 15 January 2018 and a 52-week low of Rs 977 on 3 July 2017.

The stock had outperformed the market over the past one month till 22 February 2018, sliding 1% compared with the Sensex's 5.53% fall. The stock had also outperformed the market over the past one quarter, advancing 23.71% as against the Sensex's 0.77% rise. The scrip had also outperformed the market over the past one year, surging 32.27% as against the Sensex's 17.17% rise.

The small-cap company has equity capital of Rs 16.60 crore. Face value per share is Rs 10.

Merck's board recommended payment of dividend of Rs 15 per share for the year ended 31 December 2017.

Merck is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments.

Powered by Capital Market - Live News